GlassScriptPhysician profile
Sean Kennedy
NPI 1538729314
$8,479.23
in general payments reported to CMS, 2019-2025
16 companies · $4,718 in 2025
The $4,718 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $197 · 2023: $2,233 · 2024: $1,194 · 2025: $4,718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,527 · Travel and Lodging: $1,617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,527.28 |
| Travel and Lodging | $1,617.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $4,821.08 | 2023-2025 | |
| Paragon 28, INC. | $1,369.71 | 2023 | Portfolio, Monkey Rings, Additive Orthopedics |
| Stryker Corporation | $1,211.17 | 2022-2025 | Actishield, Allomatrix, Infinity |
| Smith+Nephew, INC. | $402.33 | 2021-2025 | Grafix Pl, Collagenase Santyl, Pico 14 |
| Biocomposites INC | $139.25 | 2025 | Stimulan |
| Restor3d, INC. | $128.83 | 2024 | |
| Kerecis Limited | $120.27 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Paratek Pharmaceuticals, INC. | $89.79 | 2024-2025 | Nuzyra |
| Linvatec Corporation | $43.70 | 2023 | Quantum, In2bones USA, Fracture and Correction Colag 2 |
| Depuy Synthes Sales INC. | $26.46 | 2025 | Va-Lcp |
| Medtronic, INC. | $24.07 | 2022 | |
| Solventum Corporation | $23.70 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C. Dermatac, Activ.A.C. Ion Progress |
| Kci USA, INC. | $21.94 | 2023 | V.A.C. Veraflo, Activ.A.C. Ion Progress, Promogran Prisma |
| Evolution Surgical, INC | $19.65 | 2021 | |
| Averitas Pharma INC. | $18.64 | 2023 | Qutenza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $18.64 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.